Journal article
Clinical Endocrinology, 2022
APA
Click to copy
Moore, A. (2022). Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility. Clinical Endocrinology.
Chicago/Turabian
Click to copy
Moore, A. “Impaired Steroid Hormone Feedback in Polycystic Ovary Syndrome: Evidence from Preclinical Models for Abnormalities within Central Circuits Controlling Fertility.” Clinical Endocrinology (2022).
MLA
Click to copy
Moore, A. “Impaired Steroid Hormone Feedback in Polycystic Ovary Syndrome: Evidence from Preclinical Models for Abnormalities within Central Circuits Controlling Fertility.” Clinical Endocrinology, 2022.
BibTeX Click to copy
@article{a2022a,
title = {Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility},
year = {2022},
journal = {Clinical Endocrinology},
author = {Moore, A.}
}
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy and cause of infertility in women of reproductive age worldwide. Despite diagnostic features of anovulation, polycystic ovarian morphology, and high androgen secretion indicating the syndrome are the result of ovarian dysfunction, alterations to central neuroendocrine circuits that control reproductive capacity may drive PCOS symptoms. Resistance of gonadotrophin‐releasing hormone (GnRH) neurons in the hypothalamus to inhibition by sex steroid hormone‐negative feedback leads to a rapid frequency of pulsatile gonadotrophin secretion, which, in turn, drives the ovarian features of the disease. As GnRH neurons do not express steroid hormone receptors, impaired negative feedback is hypothesized to occur within an upstream network that controls GnRH pulse generation. This review will discuss the latest work from preclinical animal models of PCOS used to dissect the specific central mechanisms involved in impaired steroid hormone feedback. In particular, this review will focus on research that indicates neurons in the arcuate nucleus of the hypothalamus that express Kisspeptin, Neurokinin B and Dynorphin (KNDy cells) or γ‐aminobutyric acid are targets of androgen‐mediated impairment of steroid hormone feedback. Finally, this review will explore the development of therapeutic agents targeting neurons that control LH pulse frequency to resolve PCOS symptoms in the clinic.